The advantages genetics could bring to clinical development and decision-making, as well as the next steps needed to make it a valid tool in this environment, were underscored in the recent findings of two studies by research groups at Harvard More
Recent months have seen much publicity for advances in the areas of genomic biotechnology, This is a rapidly developing area and the Government has called for applications for its LINK Applied Genomics research programme More
The pharmacogenomic approach allows stratification of patient populations to achieve better efficacy of treatment, while also providing opportunities for rationalization of drug trials and identification of new markets. More
D&MD's Genomics 2000 Report, written by Mary Ortner, documents progress andchanges in the climate and business environment in the field of genomics. More
All rights reserved. Terms and Conditions | Contact us
